Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Location
1800 Owens Street, Suite 900, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 745 % -28.8%
Debt-to-equity 24.9 % +35.4%
Return On Equity -50.8 % -38.3%
Return On Assets -40.6 % -31.1%
Operating Margin -3.25K % -320%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 139M shares +1.02%
Common Stock, Shares, Outstanding 139M shares +1.69%
Entity Public Float 746M USD -58.6%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 139M shares +1.67%
Weighted Average Number of Shares Outstanding, Diluted 139M shares +1.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 16.9M USD -78.6%
Revenue from Contract with Customer, Excluding Assessed Tax 16.9M USD -89.9%
Cost of Revenue 745K USD -21.3%
Research and Development Expense 474M USD -7.01%
Costs and Expenses 565M USD -17.8%
Operating Income (Loss) -549M USD +9.93%
Nonoperating Income (Expense) 49.2M USD -29.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -499M USD +7.38%
Income Tax Expense (Benefit) 268K USD -5.09%
Net Income (Loss) Attributable to Parent -500M USD +6.31%
Earnings Per Share, Basic -3 USD/shares +7.65%
Earnings Per Share, Diluted -3 USD/shares +7.65%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 170M USD +1.03%
Marketable Securities, Current 328M USD -55.7%
Cash, Cash Equivalents, and Short-term Investments 1.19B USD -30%
Other Assets, Current 100K USD -98.7%
Assets, Current 546M USD -47.9%
Property, Plant and Equipment, Net 58.2M USD -10.2%
Operating Lease, Right-of-Use Asset 63.6M USD +4.57%
Intangible Assets, Net (Excluding Goodwill) 7.92M USD -58.9%
Goodwill 16.9M USD -0.01%
Assets 1.02B USD -32%
Accounts Payable, Current 6.85M USD -6.27%
Liabilities, Current 75.2M USD -35.8%
Contract with Customer, Liability, Noncurrent 9.43M USD
Deferred Income Tax Liabilities, Net 3.25M USD -82.4%
Operating Lease, Liability, Noncurrent 91.2M USD -2.35%
Other Liabilities, Noncurrent 13.3M USD -4.23%
Liabilities 223M USD -13.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.91M USD -270%
Retained Earnings (Accumulated Deficit) -1.15B USD -76.3%
Stockholders' Equity Attributable to Parent 796M USD -35.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 796M USD -35.8%
Liabilities and Equity 1.02B USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.1M USD +28.6%
Net Cash Provided by (Used in) Financing Activities 598K USD +293%
Net Cash Provided by (Used in) Investing Activities 127M USD +346%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 139M shares +1.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 49.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 179M USD -32.2%
Deferred Tax Assets, Valuation Allowance 453M USD +27.1%
Operating Lease, Liability 97.9M USD -21.4%
Depreciation 11.3M USD -28.5%
Payments to Acquire Property, Plant, and Equipment 1.63M USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -503M USD +5.21%
Lessee, Operating Lease, Liability, to be Paid 124M USD -21%
Property, Plant and Equipment, Gross 103M USD +2.71%
Operating Lease, Liability, Current 8.96M USD -53.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.6M USD -23.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.6M USD -32.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.6M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.9M USD -23.8%
Deferred Tax Assets, Operating Loss Carryforwards 180M USD +30.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 17.5M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.3M USD -22.5%
Additional Paid in Capital 1.95B USD +3.06%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 133K USD 0%
Depreciation, Depletion and Amortization 2.87M USD -36.5%
Deferred Tax Assets, Net of Valuation Allowance 25.5M USD -37.8%
Share-based Payment Arrangement, Expense 53.7M USD -40.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%